Great Lakes Water Quality Seventh Annual Report 1978: Appendix G Annual Report of the Committee on the Assessment of Human Health Effects of Great Lakes Water Quality by Great Lakes Water Quality Board. Committee on the Assessment of Human Health Effects of Great Lakes Water Quality & Great Lakes Science Advisory Board
University of Windsor
Scholarship at UWindsor
International Joint Commission (IJC) Digital Archive
1979-07-01
Great Lakes Water Quality Seventh Annual Report
1978: Appendix G Annual Report of the
Committee on the Assessment of Human Health
Effects of Great Lakes Water Quality
Great Lakes Water Quality Board. Committee on the Assessment of Human Health Effects of Great
Lakes Water Quality
Great Lakes Science Advisory Board
Follow this and additional works at: http://scholar.uwindsor.ca/ijcarchive
This AR is brought to you for free and open access by Scholarship at UWindsor. It has been accepted for inclusion in International Joint Commission
(IJC) Digital Archive by an authorized administrator of Scholarship at UWindsor. For more information, please contact scholarship@uwindsor.ca.
Recommended Citation
Great Lakes Water Quality Board. Committee on the Assessment of Human Health Effects of Great Lakes Water Quality, & Great
Lakes Science Advisory Board (1979). Great Lakes Water Quality Seventh Annual Report 1978: Appendix G Annual Report of the





























































ANNUAL REPORT OF THE
  
COMMITTEE
ON THE ASSESSMENT OF
HUMAN HEALTH EFFECTS OF












The 1978 Annuai Report of the International Joint Commission's Committee
on the Assessment of Human Health Effects of Great Lakes Water Quaiity was
prepared both for the Water Quaiity Board and for the Science Advisory Board.
Highiights from the activities of the Committee, from its inaugurai












































































































































One of the most important recommendations contained in the Sixth Annual
Great Lakes Water Quality Report of the International Joint Commission (1978)
has urged that the Governments of the United States and Canada “collaborate
and develop a program which establishes a running inventory of toxic chemicals
used, manufactured or imported into the Great Lakes Basin" and "evaluate their
risk to human health and the environment.” As a result of its continuing and
growing concern over the potential human health hazards of contaminants which
bioaccumulate in fish, a special committee on the Assessment of Human Health
Effects of Great Lakes Water Quality was formed in early 1978.
TERMS OF REFERENCE
In considering its mandate, the committee proposed and agreed to take the
following under its purview:






















3. Provide to the International Joint Commission through its Boards,







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































- neurobehavioural toxicity; and




































































































































































































































































































































































































































Adverse effects by route
other than oral, dermal,
or aq
uatic










































































































































































































































































































































































































































































































































































































































































































































This factor is applied in all categories other than acute toxicity.
Rationale:

















recognized that materials do vary in their potency and that very potent
substances create greater concern and demand priority consideration over less
potent materials that may evoke the development of similar qualitative effects
but only after much higher does have reached the target cells, organs or
organisms, and often only after longer periods of time.
To account for differences in potency, the rating accorded a substance
under any toxicity categoryis doubled if the material is judged to possess
strong potency.
The distinction between "strong" and "weak" potency with respect to
carcinogens has been maintained for many years. Weak carcinogens are those
which manifest their effects only after repeated dosage over a long period of






















































4 The chemical has been demonstrated to be a human positive
carcinogen (defined in (a) below) by the oral, dermal or
inhalation route of exposure.
2 The chemical has been demonstrated to be a suspected carcinogen
(defined in (c) below) by the oral, dermal, or inhalation route
of exposure.
1 The chemical has been demonstrated by accepted mutagenicity
screening tests or accepted cell transformation studies to be a
potential carcinogen (defined in (d)).
0 The chemical has been tested by the above systems and has not
been demonstrated to cause cancer or to be a potential
8
 carcinogen.



















































































































































































































































































































clinical studies to cause cancer in man.




































































































































































































but not confirmed in another species.

























































0 Chemical which has been shown to transform normal human or
normal mammalian cells into tumour cells in replicated tests












2 Suspect teratogen in multicellular organisms
1 Suspect mutagen in microorganisms




Neurotoxicity and the potential of a chemical to cause behavioral changes
in mammals or other animals will be assessed according to the following scores:
Score Category
4 Confirmed human neurotoxic chemical
3 Confirmed animal neurotoxic agent, therefore suspect in humans
1 Suspect animal neurotoxic chemical




4 Chemicals known to cause nervous system malfunctions and/or
pathology, behavioral disorders including learning disabilities
in humans, will be considered as confirmed neurotoxic agents for
humans.
3 Chemicals causing neuropathies in experimental animals will be
considered suspect neurotoxic agents for humans.
1 Chemicals shown to cause only behavioral changes in animals will
be considered potentially suspect neurotoxic agents for animals.
10
 0 A chemical, adequately tested for neurobehavioral toxicity with
negative findings will be considered inactive as a neurotoxic
agent.
* Where insufficient information is available testing should be
considered.
Score Category
Confirmed human neurotoxic chemical
Confirmed animal neurotoxic agent, therefore suspect in humans











VI. CHRONIC ADVERSE EFFECTS
Introduction and Rationale:
The category "Chronic Adverse Effects" contains a large variety of toxic
effects on a variety of target organs and tissue. Some have been left out
because they were considered unlikely to be affected by chemicals in the water
of the Great Lakes. Wherever possiblehowever the systems are included and
scores proposed with occasional examples, which may be deleted.
The wording is usually too short and thus unclear. When effects are
observed they are adverse irreversible effects unless otherwise stated. When




















humans were not exposed to the chemicals. Human data are obtained from
epidemiological studies and not from clinical reports only, which may be
erroneous in the association proposed.
When no adverse effects are observed it means that no serious adverse
effects are found. Weight loss can always be produced with a high enough dose
with any choice of chemical, but that is not meant here.
No attention was paid to genetic weakness of human populations, although
the means to do so exist. However, in experiments on animals it has









































N.B. Unless specified the effects are irreversible and/or
progressive
Effects observed in humans (e.g., cataracts)







1 Reversible effects observed in humans or animals




























































2 Effects not observed in humans, but in animal experiments
1 Reversible effects observed in humans or animals (e.g.,
bilirubinemia)
0 No adverse effects observed
* No information



















replace the lost tissue.
(c) Urinary System
Score Category
3 Effects in humans
2 Effects not observed in humans, but in animal experiments
1 Reversible effects in humans or animals
0 No effects observed
*
No information
It is suggested including in these categories adverse effects observed, as for





























2 Effects not observed in humans, but in animal experiments
1 Reversible effects observed in humans or animals
0 No effects observed ,
* No information
A weighting factor of 2x is proposed for the adverse effects of this
chemical if the impaired health (due to other causes) will considerably
aggravate the toxicity of the chemical. The same consideration applies to the
respiratory system and the lymphatic system.
12
 (e) Respiratory System
Score Category















































































































(f) Blood Forming System
Score Category
























































































































































































































































































































































































































































































1 Reversible effects in humans or animals










































chemicals entering the 6.1. tract.
(k) Skin
Score Category









































producing abnormal absorption of chemicals or aggravation of effect.
The committee is currently evaluating the 400 compounds identified in the
Water Quality Board's report (193. gig) utilizing the above categories of
criteria and scoring systems.
14
 ESTIMATES OF HUMAN EXPOSURE
FROM ENVIRONMENTAL DATA
Possible health effects of Great Lakes water quality from any chemical
compound or agent are a function of both the toxic (carcinogenic) properties
of the compound and the possible exposure of man to it.
In order to be concerned about a compound, we consider exposure of any
identifiable group of people, however small, and in any area in the Great
Lakes Basin, however limited in size.
Exposure is determined by:
1. Inputs into the Great Lakes and the resulting concentrations in the
several compartments of the Great Lakes ecosystem.
2. Rates of transformation and translocation within'and between compartments.
3. Intake by man of water or food from these compartments.
Beginning with point (3) we identify the following target populations:
(a) Any local population deriving their drinking water from the Great
Lakes.
(b) Any local population deriving a substantial portion of their total
food intake from Great Lakes fish.
(c) Any local population consuming waterfowl (hunters and their families).
(d) Any local population deriving a significant portion of their food
from land irrigated with Great Lakes water or from livestock drinking
Great Lakes water.
The following additional target populations are recognized as part of the
greater ecosystem of the Great Lakes but are excluded from considerations of
Great Lakes water quality.
(e) Local populations deriving food from land receiving wastewater
sludges.
(f) Populations exposed in the occupational, domestic, and urban
environment to contaminants identified in Great Lakes water and
traceable to land sources.
Exposures from (e) to (f) must be taken into account also in determining
total exposure of a local population to the contaminant.
Input and concentration data are the points of departure for estimates of







        
,,”OTHER EIXPOSURES \\
’ \
        
INPUTS FROM INPUTS FROM
POINT SOURCES NON—POINT SOURCES
1. POTABLE WATER
INPUTS FROM PRECIPITATION 2, IMMERSION
EFFLUENT PLANKTON Egg FISH



















available from measurements of concentrations and flows, or from estimates of
production, use, and loss of chemicals. Input data are related to
concentration data by factors such as dilution, partition, chemical or
microbial degradation, bioaccumulation, etc., (marked by arrows in Figure 1).
For some compounds, the data base available involves numerous measurements
of the compounds in several compartments over a large part of the Great Lakes
Basin. For other compounds, data are sparse and are available only for
limited areas and few, or one compartment of the ecosystem. For the areas
known to show measurable concentrations of the compounds, order-of-magnitude
estimates of concentrations in other compartments in the same area can be made
by applying conversion factors on dilution, partition, degradation, and
bioaccumulation. Extrapolation to other areas in the basin is difficult and
would be based on known patterns of production and use of chemicals,
generalizations on likely sources, etc. In order to undertake this effort,
the group recommends the reworking of the available data base (Great Lakes
Water Quality Board - Appendix E, Status Report on Organic and Heavy Metal
Contaminants in the Lakes Erie, Michigan, Huron and Superior Basins, IJC,
Windsor, Ontario, July 1978) into a more useful format giving for each
compound, the available data by geographic location and by compartment (amount
discharged or effluent concentration measured, concentration in sludge,
concentration in water, concentration in sediment, concentration in fish,
concentration in other biota). This information will then be analyzed by the
above procedures to derive estimates of exposure for any of the possible
target populations.
This estimate of the exposure together with data on toxicity, including
factors such as carcinogenicity, persistence in man, etc., for each compound
will produce a measure of concern by the committee for public health effects
from any given compound, refined as is possible by estimates of synergistic
and other interactions among compounds. If effect levels are known for a
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 INTERACTIONS IN TOXICOLOGY:
AN OVERVIEW
Interactions in drugs as suggested in the translation of the Papyrus Ebers
is an ancient interest (Rossi, '63). The course of history of interactions in
toxicology would run parallel to that for drugs since no drug is free of toxic
effects (Fingl and Woodbury, '70). Accumulated knowledge of drug
interactions, however, is much greater than interactions in toxicology (James,
£5 31., '78). This latter statement would be expected when one considers the
age difference between these two sciences. Man, not necessarily man the
scientist, has been interested for centuries in the basic effect of a poison.
How it worked, or interacted, was not his concern as long as the measured
effect, death, was achieved. From that simple observation of yesterday,
scientists today are turning more earnestly to the “question of interaction of
the causes" (Rothman, '76).
Interactions in toxicology are no longer viewed as a basic biochemical
event but they are recognized as complex, complicated and controversial.
Assessment of a toxicant is interrelated to nutrition, stress, age, sex,
genetics, prior or concurrent diseases, body weight, route of administration,
its pharmacokinetics and the environment. With so many diverse factors
affecting the observed effect the underlying mechanism becomes very difficult
to solve or understand (i.e., complicated). Controversies will undoubtedly
arise because most interactions in toxicology have not been resolved.
Foremost among these controversies are the problems of interactions with
minute or large dosages of a chemical carcinogen (Maugh, '78). The task of
this overview is to look at interactions in toxicology, excluding drug
toxicology. Drug toxicology cannot be completely forgotten because many of
the terms and ideas of interactions in pharmacology have entered toxicology.
This presentation contains a brief outline of interactions; its definition,
types and controversies. The basic intention is that of an outline. Models
and approaches to assessing interactions in toxicology are also present.
Definition
The word interaction is too often used in a facile manner to confer an
understanding of a sequence of biochemical events for which little or nothing
is known. It is used to bridge the veiled gap between (i.e., inter-) cause
and effect. An illusion is presented, analogous to the use of the word
evolution, that the measured effect can be attributed to an interaction. Yet,
no explanation is given to or is known of the series of biochemical events
which comprise the interaction. The truth in most instances is that we do not
know, as yet, the mechanisms of interactions. A discussion of interactions,
more often than not, describes the measured effect with little reference to
the causal mechanism.
Death is the easiest measured effect of an interaction. To gain an

















































































































































































































































































































































































































































































































































































































































































































































































































activities of the compounds" (Veldstra, '56). Others adhere to the
epistemological meaning.




















as being similar to that definition used in pharmacology; "the cooperative








































 Magos ('74), however, considers that when "the action can be greater than the
algebraic summation" it is supplemental synergism or potentiation. He also
uses the term "additive synergism" as the simple algebraic sum. Veldstra
('56) argues against the use of the term potentiation.
Interactions which produce synergistic effects are not an exception but a
common occurrence. Some food additives have a synergistic toxic effect when
incorporated in a purified, low fiber, diet (Ershoff, '76). Herbicides can
increase the toxicity of insecticides to potencies greater than either given
alone (Lichtenstein, e: 31. '73). Methylmercury in combination with nitrite
and ethylurea reduced survival of progeny (Nixon, '77). Combinations of
aflatoxin B, and Fusarium toxic, T—Z, produced a synergistic lethal response
(Lindenfelser, gt g1. '74). The herbicide silvex is degraded by the
synergistic action of aquatic microorganisms (Ou and Sikka, '77). Hicks and
Chowaniec ('77) studied the importance of synergy between weak carcinogens and
bladder tumours.
Veldstra ('56) states that the term "potentiate" should be discontinued
because it means "to endow with power" and in combination the resident
"power," viz. specific activity, is not altered but "the effectiveness of the
power already present is enhanced." Fingl and Woodbury ('70) agree with
Veldstra that potentiation should be abandoned. Rossi ('63) notes that
Webster's dictionary provides some justification for its use; potentiate - "to
make potent or more effective." Scientists may be using "potentiate" in the
same sense that it is employed in physics, that is, energy which is involved
because of position or condition. Magos ('74) defines potentiation, also
called supplemental synergism, as an action greater than the algebraic
summation. The latter definition is the same as that given to synergism.





































































































































































































































































































































































































































































































































































































































































bioassay was reported for detecting both synergistis and antagonists of
paraoxon and malaoxon (Cohen and Murphy, '73).
Controversies





































































































































DNA. Gehring ('76) has demonstrated that the pharmacokinetics do change with

















































































































































































































































































a citation of mechanisms of interaction that are known.
Dubois, et al. ('68) provided the explanation for the synergistic effect



























































 ('72) reported other possible mechanisms of interaction for insecticides.
Mechanisms of interaction, briefly presented in the preceding paragraph,
have not completely eluded research, however; they are complex, complicated
and controversial.
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 photomirex is 10—100 times more toxic than mirex and 5 times more toxic than
kepone. In rat feeding studies, photomirex was observed to produce lesions in
the testes, thyroid and liver of male rats. Subsequent experiments have shown
that this compound causes ultrastructural alterations in the liver and testes
at extremely low levels, and that the alterations persist for up to a year
after photomirex exposure has ceased. Like its parent compound mirex,
photomirex is also able to produce cataracts in suckling rats whose mothers
are exposed to the compound. Metabolism and pharmacokinetic data have shown
that photomirex is not metabolized in rats to any significant degree, and is
not excreted in the bile. The main excretory route is through the feces.
Conclusions
The data presented at the meeting on photomirex indicate that this compound
could have greater potential as a human health hazard than mirex. This
example serves to indicate that Great Lakes Monitoring and Surveillance
Programs should be designed not only to provide data on parent compounds, but
also on their degradation products.
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LEAD
In its Final Report, PLUARG drew attention to its concern over the build
up of lead in sediments, particularly in Lakes Erie and Ontario. Studies
undertaken by PLUARG suggest that non-point sources are by far the greatest
component of the load.
Concern over lead at this time arises not from any evidence that current
levels of lead in drinking water or fish tissues exceed health-based
regulatory standards, but because of recent evidence that inorganic lead in
sediments may be transformed into more toxic organic forms by biological
mechanisms in Great Lakes sediments.
The major diffuse source of lead in the Great Lakes Basin is the
automobile. Alkyl lead compounds have been extensively used to improve the
combustion characteristics of gasoline. When burned in the gasoline engine,
most lead in gasoline is converted into inorganic form and emitted as halides
which subsequently are converted during aging to oxides, sulphates and
carbonates. In these compounds, lead is in particulate form and settles over
the landscape as dust. Lead from automobile exhausts enters the aquatic
system primarily in surface run-off although a small proportion undoubtedly
28
 
 enters the lakes through atmospheric fallout and precipitation.
In 1975-76, three different groups of scientists (including one from the
Canada Centre for Inland Waters, the others being in the United Kingdom and in
Germany) reported that micro-organisms can methylate organic and inorganic
lead compoundsl-3. By analogy with mercury, the Comnittee had concern that
the existence of methylated lead in the environment could lead to the
recognition of hitherto unsuspected toxic effects.
The Committee reviewed the evidence relating to biomethylation of lead in
the aqueous environment. It noted a recent report of the World Health
Organization's Task Group on Environmental Health Criteria for Lead which
concludes that:
"Acute toxicity results in an encephalopathy that differs
greatly from the effects of inorganic lead on the central
nervous system. Some components of the toxic effect are
probably due to the alkyl compound as a whole rather than
its lead components.“
The Comnittee concluded that the substrates, conditions and mechanisms
which may lead to alkylation of lead in the environment are not known at the
present time, and it recognizes the need for improvements in analytical
methods and quality control procedures. Nevertheless, it considers that there
is a need for exploratory measurements to be made to determine whether
alkylated lead compounds are present in sediments, algae, invertebrates, fish
and wildlife from the Great Lakes, and, if so, in what form and in what




























































































































During 1978, the committee proposed to both Boards, the following
activities for inclusion in the IJC Regional Office program budget.
1.
A Study on Intervention Guidelines for Great Lakes Environmental
Contaminants in Fish
A survey would be made of the appropriate regulatory agencies in the
Great Lakes Basin to determine and document the philosophy underlying
the rationale used in setting standards for individual environmental
contaminants in fish.
The assignment would be contracted to an individual familiar with the
regulatory agencies concerned and with their appropriate
representatives, at all levels of government affecting the Great
Lakes. Hence, a period of extensive travelling would be anticipated
by the consultant.
The study would aid in clarifying cases of diSparity among different
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